The firing of FDA staff involved in reviewing Neuralink’s applications, allegedly coinciding with layoffs at DOGE, raises serious concerns about potential conflicts of interest and regulatory capture. The timing is undeniably suspicious, leading many to question whether these dismissals were merely coincidental or a deliberate attempt to influence the regulatory process.
The narrative that Elon Musk holds no legal authority over DOGE and therefore couldn’t orchestrate these firings seems questionable, given the interconnectedness of his business empire and the influence he wields. The sheer scale of resources and power at his disposal makes it difficult to dismiss this as a simple coincidence.… Continue reading
Over the weekend, approximately 20 FDA employees in the office of neurological and physical medicine devices were terminated, impacting the agency’s review of medical device applications, including those from Neuralink. While the firings weren’t explicitly targeted at Neuralink reviewers, the loss of these employees, many of whom worked on Neuralink’s applications, will hinder the agency’s efficiency and potentially compromise safety. These probationary employees were dismissed despite positive performance reviews, raising concerns about the process and potential implications for Neuralink’s clinical trials. Outside experts express worry about the impact on the safety of trial participants.
Read More
Neuralink’s first in-human brain implant has experienced a problem, according to the company. Now, when I first heard about this, I couldn’t help but think about all the classic science fiction movies and novels that warn us about the dangers of such advanced technology. It’s like a real-life version of a cautionary tale unfolding before our eyes.
But let’s not jump to conclusions just yet. The issue seems to be that some of the wires connecting the electrodes have retracted, resulting in a decreased total access to them. However, the implant still functions, and adjustments have been made to the algorithm to account for this setback.… Continue reading
Matt Underwood 
John Q. Hosedrinker